Skip to content

En español

Xgeva

Page last modified on: December 6, 2011

Brand name: Xgeva

Chemical name: Denosumab

Class: RANKL inhibitor

How it works: RANKL inhibitors block the RANKL protein, limit the activity level of certain bone cells, called osteoclasts, which help cause the bone weakening and damage that can happen when breast cancer spreads to the bone. RANKL inhibitors also can help keep blood calcium levels normal. This is important because bone damage may increase blood calcium.

Uses: Xgeva is used to reduce bone complications and bone pain caused by advanced-stage breast cancer that has spread to the bone. It's usually given with other chemotherapy medicines.

How it's given: Xgeva is given as an injection under the skin.

Side effects:

Was this resource helpful?

Yes No

Thank you for your input!

Together we can make a difference

Email Updates

Stay informed about current research, online events, and more.

Please leave this field empty
Visit our Gift Shop!
Back to top

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

©2012 Breastcancer.org - All rights reserved.

charity_navigator

View Mobile Site